-
<![CDATA[Efanesoctocog Alfa Improves Bleeding Regardless of Age in Hemophilia A, With Lynn Malec, MD, MSc]]>
17 Dec 2025 00:53 GMT
Once-weekly efanesoctocog alfa is both well tolerated and efficacious in providing bleed protection to adult, adolescent, and child patients with severe hemophilia A, according to results from the XTEND-ed study.1
These data were presented at the 67th …
-
Minimizing Post-Operative Scars in External Dacryocystorhinostomy: A Literature Review
16 Dec 2025 20:19 GMT
… Nordic, Medistim, Novartis, Santen, Specsavers, Shire Pharmaceuticals and Théa Laboratories. The author …
-
NexGelRx Receives Additional Investment from Eric Gruntfest of Diesis Holdings, LLC and Appoints Him as Board Observer and Strategic Advisor
16 Dec 2025 13:00 GMT
… leadership roles at Medtronic, MiMedx, Shire, and Celgene, with a strong … for a wide array of pharmaceuticals.” About NEXGEL, Inc.
NEXGEL is …
-
Blood Plasma Derivatives Market Set to Witness Significant Growth by 2025-2032 | Shire Plc., CSL Limited, Octapharma AG
15 Sep 2025 10:38 GMT
Blood Plasma Derivatives Market is estimated to valued USD 52.96 Bn in 2025 and expected to reach USD 98.69 Bn by 2032, growing CAGR of 9.3% from 2025 to 2032
BURLINGAME, CA, UNITED STATES, September 15, 2025 /EINPresswire.com/ -- Coherent …
-
Plastic Surgery Expert Dr. James Shire Shares Tips and Considerations for Eyelid Surgery in HelloNation
11 Aug 2025 21:00 GMT
What should someone consider before choosing eyelid surgery?
CHATTANOOGA, TN, UNITED STATES, August 11, 2025 /EINPresswire.com/ -- What should someone consider before choosing eyelid surgery? In a feature article for HelloNation, facial plastic …
-
Unifying life sciences insights to accelerate enterprise value
08 Dec 2025 11:57 GMT
Strategic Imperative for C-Suite Leaders
Life sciences organizations are often inundated with data: across commercial, medical affairs, R&D and manufacturing. Yet often, insights remain fragmented and disconnected from decisions driving growth. The …
-
Kingscliff redevelopment approved
04 Dec 2025 22:21 GMT
Uniting NSW.ACT has received approval from the New South Wales government for its Kingscliff redevelopment in the Tweed Shire, northern NSW.
Uniting NSW.ACT chief executive officer Tracey Burton said the plans for Uniting Kingscliff have been caught in an …
-
Tonix Pharmaceuticals Announces Appointment of Commercial Industry Veteran, James “Jim” Hunter, to Board of Directors
13 Jun 2025 11:00 GMT
… Chief Executive Officer of Tonix Pharmaceuticals. “Having successfully built Tonix … acquisitions from companies such as Shire, Roche, Novartis and Sanofi. … Investor Contact Jessica Morris
Tonix Pharmaceuticals
investor.relations@tonixpharma.com
(862 …
-
Hyperphosphatemia Drugs Market Rising Demand to Drive 9.2% CAGR, Reaching USD 6.7 Billion by 2032 | CMI
03 Dec 2025 12:37 GMT
… in hyperphosphatemia drugs market report:
Shire Pharmaceuticals
Amgen Inc.
Vifor Pharma
Kyowa …
-
Co-Founder of Shire Pharmaceuticals Appointed as Chief Operating Officer of Klotho Neurosciences
15 Oct 2024 10:00 GMT
… Peter Moriarty, Co-Founder of Shire Pharmaceuticals, as its Chief Operating Officer … by his co-founding of Shire Pharmaceuticals. He brings a wealth of …